JPRN-UMIN000000855已完成2 期
A phase II study to evaluate the effect on the combination chemotherapy of CPT-11 and S-1 for advanced/recurrent colon cancer which combines genetic analysis on adverse events (OGSG 0405) - OGSG 0405
OGSG0 个研究点目标入组 30 人开始时间: 2007年10月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. without interstitial pneumonia or pulmonary fibrosis on X-ray examination And/or clinical signs 2. Cavity fluid which needs drainage 3. with active double cancer except ca. in situ 4. with intestinal paralysis or obstruction 5. under watery diarrhea 6. with uncontrolled DM 7. with ischemic cardiac disease 8. with mental disorder which disturbs registration to this study 9. with infectious disease which needs treatment 10. patients who receive steroids treatment 11. Cardiac failure, liver dysfunction, or renal dysfunction which disturb Registration to this study 12. with brain metastasis and the symptom due to the metastasis 13. pregnant women or women who like to be pregnant 14. history of severe allergy against drug 15. doctor's dicision not to be registered to this study
研究者
相似试验
进行中（未招募）
1 期
A preliminary study is planned to check two different treatment options for the management of infection of the pulp in lower molar teeth.CTRI/2018/06/014426Centre for Dental Education and Research
进行中（未招募）
不适用
Phase IIa study to investigate the efficacy of NOX-H94 in the treatment of anemia in patients with cancer.anemia of chronic disease in patients with cancerMedDRA version: 16.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 100000004864MedDRA version: 16.0Level: LLTClassification code 10054310Term: Anemia of chronic diseaseSystem Organ Class: 100000004851EUCTR2012-001525-27-ATOXXON Pharma AG48
进行中（未招募）
1 期
Phase IIa study to investigate the efficacy of NOX-H94 in the treatment of anemia in patients with cancer.EUCTR2012-001525-27-BGOXXON Pharma AG48
招募中
2 期
Phase IIa Study to Characterize the Effects of the Spiegelmer® NOX H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or LymphomaD63.0Anaemia in neoplastic diseaseAnemia of Chronic DiseaseDRKS00004366OXXON Pharma AG48
招募中
2 期
A Phase II Study to Investigate the Efficacy and Safety of Oral intake of Anamorelin in Patients After Total GastrectomyAfter Total GastrectomyJPRN-jRCTs041230012Bando Etsuro65